{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:58:14Z","timestamp":1787003894615,"version":"build-2736575974"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2016,10,4]],"date-time":"2016-10-04T00:00:00Z","timestamp":1475539200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,10,4]],"date-time":"2016-10-04T00:00:00Z","timestamp":1475539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Psychotic disorders affect ~3% of the general population and are among the most severe forms of mental diseases. In early stages of psychosis, clinical aspects may be difficult to distinguish from one another. Undifferentiated psychopathology at the first-episode of psychosis (FEP) highlights the need for biomarkers that can improve and refine differential diagnosis. We investigated gene expression differences between patients with FEP\u2013schizophrenia spectrum (SCZ;\n                    <jats:italic>N<\/jats:italic>\n                    =53) or FEP\u2013Mania (BD;\n                    <jats:italic>N<\/jats:italic>\n                    =16) and healthy controls (\n                    <jats:italic>N<\/jats:italic>\n                    =73). We also verified whether gene expression was correlated to severity of psychotic, manic, depressive symptoms and\/or functional impairment. All participants were antipsychotic-naive. After the psychiatric interview, blood samples were collected and the expression of 12 psychotic-disorder-related genes was evaluated by quantitative PCR.\n                    <jats:italic>AKT1<\/jats:italic>\n                    and\n                    <jats:italic>DICER1<\/jats:italic>\n                    expression levels were higher in BD patients compared with that in SCZ patients and healthy controls, suggesting that expression of these genes is associated more specifically to manic features. Furthermore,\n                    <jats:italic>MBP<\/jats:italic>\n                    and\n                    <jats:italic>NDEL1<\/jats:italic>\n                    expression levels were higher in SCZ and BD patients than in healthy controls, indicating that these genes are psychosis related (independent of diagnosis). No correlation was found between gene expression and severity of symptoms or functional impairment. Our findings suggest that genes related to neurodevelopment are altered in psychotic disorders, and some might support the differential diagnosis between schizophrenia and bipolar disorder, with a potential impact on the treatment of these disorders.\n                  <\/jats:p>","DOI":"10.1038\/tp.2016.159","type":"journal-article","created":{"date-parts":[[2016,10,4]],"date-time":"2016-10-04T11:39:44Z","timestamp":1475581184000},"page":"e908-e908","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Gene expression alterations related to mania and psychosis in peripheral blood of patients with a first episode of psychosis"],"prefix":"10.1038","volume":"6","author":[{"given":"E S","family":"Gouvea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V K","family":"Ota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Noto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M L","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L M","family":"Spindola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P N","family":"Moretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C M","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Xavier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A C","family":"Rios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J R","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M A F","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Brietzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Gadelha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R A","family":"Bressan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q","family":"Cordeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S I","family":"Belangero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,4]]},"reference":[{"key":"BFtp2016159_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1001\/archpsyc.64.1.19","volume":"64","author":"J Perala","year":"2007","unstructured":"Perala J, Suvisaari J, Saarni SI, Kuoppasalmi K, Isometsa E, Pirkola S et al. Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch Gen Psychiatry 2007; 64: 19\u201328.","journal-title":"Arch Gen Psychiatry"},{"key":"BFtp2016159_CR2","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1080\/08039480903009118","volume":"63","author":"M Bogren","year":"2009","unstructured":"Bogren M, Mattisson C, Isberg PE, Nettelbladt P . How common are psychotic and bipolar disorders? A 50-year follow-up of the Lundby population. Nord J Psychiatry 2009; 63: 336\u2013346.","journal-title":"Nord J Psychiatry"},{"key":"BFtp2016159_CR3","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1192\/S0007125000297663","volume":"172","author":"M Birchwood","year":"1998","unstructured":"Birchwood M, Todd P, Jackson C . Early intervention in psychosis. The critical period hypothesis. Br J Psychiatry Suppl 1998; 172: 53\u201359.","journal-title":"Br J Psychiatry Suppl"},{"key":"BFtp2016159_CR4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/schbul\/sbr100","volume":"38","author":"A Demjaha","year":"2012","unstructured":"Demjaha A, MacCabe JH, Murray RM . How genes and environmental factors determine the different neurodevelopmental trajectories of schizophrenia and bipolar disorder. Schizophr Bull 2012; 38: 209\u2013214.","journal-title":"Schizophr Bull"},{"key":"BFtp2016159_CR5","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/j.jpsychires.2013.07.019","volume":"47","author":"M Fuste","year":"2013","unstructured":"Fuste M, Pinacho R, Melendez-Perez I, Villalmanzo N, Villalta-Gil V, Haro JM et al. Reduced expression of SP1 and SP4 transcription factors in peripheral blood mononuclear cells in first-episode psychosis. J Psychiatr Res 2013; 47: 1608\u20131614.","journal-title":"J Psychiatr Res"},{"key":"BFtp2016159_CR6","volume-title":"Manic-Depressive Insanity and Paranoia","author":"E Kraepelin","year":"1919","unstructured":"Kraepelin E . Manic-Depressive Insanity and Paranoia. E. & S. Livingstone: Edinburgh, UK, 1919."},{"key":"BFtp2016159_CR7","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1586\/14737159.2016.1171714","volume":"16","author":"J van de Leemput","year":"2016","unstructured":"van de Leemput J, Glatt SJ, Tsuang MT . The potential of genetic and gene expression analysis in the diagnosis of neuropsychiatric disorders. Expert Rev Mol Diagn 2016; 16: 677\u2013695.","journal-title":"Expert Rev Mol Diagn"},{"key":"BFtp2016159_CR8","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1192\/bjp.bp.114.145433","volume":"205","author":"KV Wirgenes","year":"2014","unstructured":"Wirgenes KV, Tesli M, Inderhaug E, Athanasiu L, Agartz I, Melle I et al. ANK3 gene expression in bipolar disorder and schizophrenia. Br J Psychiatry 2014; 205: 244\u2013245.","journal-title":"Br J Psychiatry"},{"key":"BFtp2016159_CR9","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/mp.2014.82","volume":"20","author":"Z Zhao","year":"2015","unstructured":"Zhao Z, Xu J, Chen J, Kim S, Reimers M, Bacanu SA et al. Transcriptome sequencing and genome-wide association analyses reveal lysosomal function and actin cytoskeleton remodeling in schizophrenia and bipolar disorder. Mol Psychiatry 2015; 20: 563\u2013572.","journal-title":"Mol Psychiatry"},{"key":"BFtp2016159_CR10","doi-asserted-by":"publisher","first-page":"e86469","DOI":"10.1371\/journal.pone.0086469","volume":"9","author":"NR Smalheiser","year":"2014","unstructured":"Smalheiser NR, Lugli G, Zhang H, Rizavi H, Cook EH, Dwivedi Y . Expression of microRNAs and other small RNAs in prefrontal cortex in schizophrenia, bipolar disorder and depressed subjects. PLoS ONE 2014; 9: e86469.","journal-title":"PLoS ONE"},{"key":"BFtp2016159_CR11","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jpsychires.2014.05.012","volume":"56","author":"VK Ota","year":"2014","unstructured":"Ota VK, Noto C, Gadelha A, Santoro ML, Ortiz BB, Andrade EH et al. Evaluation of neurotransmitter receptor gene expression identifies GABA receptor changes: a follow-up study in antipsychotic-naive patients with first-episode psychosis. J Psychiatr Res 2014; 56: 130\u2013136.","journal-title":"J Psychiatr Res"},{"key":"BFtp2016159_CR12","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1016\/j.psychres.2013.09.016","volume":"210","author":"VK Ota","year":"2013","unstructured":"Ota VK, Noto C, Gadelha A, Santoro ML, Silva PN, Melaragno MI et al. Neurotransmitter receptor and regulatory gene expression in peripheral blood of Brazilian drug-naive first-episode psychosis patients before and after antipsychotic treatment. Psychiatry Res 2013; 210: 1290\u20131292.","journal-title":"Psychiatry Res"},{"key":"BFtp2016159_CR13","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.schres.2014.05.015","volume":"157","author":"ML Santoro","year":"2014","unstructured":"Santoro ML, Ota VK, Stilhano RS, Silva PN, Santos CM, Diana MC et al. Effect of antipsychotic drugs on gene expression in the prefrontal cortex and nucleus accumbens in the spontaneously hypertensive rat (SHR). Schizophr Res 2014; 157: 163\u2013168.","journal-title":"Schizophr Res"},{"key":"BFtp2016159_CR14","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1017\/S1461145713000035","volume":"16","author":"N Kumarasinghe","year":"2013","unstructured":"Kumarasinghe N, Beveridge NJ, Gardiner E, Scott RJ, Yasawardene S, Perera A et al. Gene expression profiling in treatment-naive schizophrenia patients identifies abnormalities in biological pathways involving AKT1 that are corrected by antipsychotic medication. Int J Neuropsychopharmacol 2013; 16: 1483\u20131503.","journal-title":"Int J Neuropsychopharmacol"},{"key":"BFtp2016159_CR15","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1001\/archpsyc.65.4.395","volume":"65","author":"RC Padmos","year":"2008","unstructured":"Padmos RC, Hillegers MH, Knijff EM, Vonk R, Bouvy A, Staal FJ et al. A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes. Arch Gen Psychiatry 2008; 65: 395\u2013407.","journal-title":"Arch Gen Psychiatry"},{"key":"BFtp2016159_CR16","doi-asserted-by":"publisher","first-page":"e69082","DOI":"10.1371\/journal.pone.0069082","volume":"8","author":"CL Clelland","year":"2013","unstructured":"Clelland CL, Read LL, Panek LJ, Nadrich RH, Bancroft C, Clelland JD . Utilization of never-medicated bipolar disorder patients towards development and validation of a peripheral biomarker profile. PLoS ONE 2013; 8: e69082.","journal-title":"PLoS ONE"},{"key":"BFtp2016159_CR17","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1399-5618.2009.00776.x","volume":"12","author":"A Gutierrez-Fernandez","year":"2010","unstructured":"Gutierrez-Fernandez A, Gonzalez-Pinto A, Vega P, Barbeito S, Matute C . Expression of oligodendrocyte and myelin genes is not altered in peripheral blood cells of patients with first-episode schizophrenia and bipolar disorder. Bipol Disord 2010; 12: 107\u2013109.","journal-title":"Bipol Disord"},{"key":"BFtp2016159_CR18","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.euroneuro.2015.02.002","volume":"25","author":"R Machado-Vieira","year":"2015","unstructured":"Machado-Vieira R, Zanetti MV, Teixeira AL, Uno M, Valiengo LL, Soeiro-de-Souza MG et al. Decreased AKT1\/mTOR pathway mRNA expression in short-term bipolar disorder. Eur Neuropsychopharmacol 2015; 25: 468\u2013473.","journal-title":"Eur Neuropsychopharmacol"},{"key":"BFtp2016159_CR19","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.schres.2011.07.007","volume":"132","author":"DM Christofolini","year":"2011","unstructured":"Christofolini DM, Bellucco FT, Ota VK, Belangero SI, Cernach MC, Gadelha A et al. Assessment of 22q11.2 copy number variations in a sample of Brazilian schizophrenia patients. Schizophr Res 2011; 132: 99\u2013100.","journal-title":"Schizophr Res"},{"key":"BFtp2016159_CR20","doi-asserted-by":"crossref","unstructured":"Noto C, Ota VK, Santoro ML, Gouvea ES, Silva PN, Spindola LM et al. Depression, cytokine, and cytokine by treatment interactions modulate gene expression in antipsychotic naive first episode psychosis. Mol Neurobiol 2015; e-pub ahead of print 22 October 2015; doi:10.1007\/s12035-015-9489-3.","DOI":"10.1007\/s12035-015-9489-3"},{"key":"BFtp2016159_CR21","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.schres.2014.09.008","volume":"159","author":"VK Ota","year":"2014","unstructured":"Ota VK, Noto C, Gadelha A, Santoro ML, Spindola LM, Gouvea ES et al. Changes in gene expression and methylation in the blood of patients with first-episode psychosis. Schizophr Res 2014; 159: 358\u2013364.","journal-title":"Schizophr Res"},{"key":"BFtp2016159_CR22","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1016\/j.euroneuro.2015.09.013","volume":"25","author":"VK Ota","year":"2015","unstructured":"Ota VK, Noto C, Santoro ML, Spindola LM, Gouvea ES, Carvalho CM et al. Increased expression of NDEL1 and MBP genes in the peripheral blood of antipsychotic-naive patients with first-episode psychosis. Eur Neuropsychopharmacol 2015; 25: 2416\u20132425.","journal-title":"Eur Neuropsychopharmacol"},{"key":"BFtp2016159_CR23","doi-asserted-by":"crossref","unstructured":"Santoro ML, Gadelha A, Ota VK, Cunha GR, Asevedo E, Noto CS et al. Gene expression analysis in blood of ultra-high risk subjects compared to first-episode of psychosis patients and controls. World J Biol Psychiatry 2015 16 441\u2013446.","DOI":"10.3109\/15622975.2015.1048724"},{"key":"BFtp2016159_CR24","unstructured":"Vessoni AL . Adapta\u00e7\u00e3o e estudo de confiabilidade da escala de avalia\u00e7\u00e3o das s\u00edndromes positiva e negativa para a esquizofrenia no Brasil. S\u00e3o Paulo Escola Paulista de Medicina 1993."},{"key":"BFtp2016159_CR25","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1590\/S1516-44462007000300010","volume":"29","author":"MS Lima","year":"2007","unstructured":"Lima MS, Soares BG, Paoliello G, Machado Vieira R, Martins CM, Mota Neto JI et al. The Portuguese version of the Clinical Global Impression-Schizophrenia Scale: validation study. Rev Bras Psiquiatr 2007; 29: 246\u2013249.","journal-title":"Rev Bras Psiquiatr"},{"key":"BFtp2016159_CR26","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0920-9964(98)00029-2","volume":"32","author":"RA Bressan","year":"1998","unstructured":"Bressan RA, Chaves AC, Shirakawa I, de Mari J . Validity study of the Brazilian version of the Calgary Depression Scale for Schizophrenia. Schizophr Res 1998; 32: 41\u201349.","journal-title":"Schizophr Res"},{"key":"BFtp2016159_CR27","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1590\/1516-4446-2013-1330","volume":"36","author":"CH Higuchi","year":"2014","unstructured":"Higuchi CH, Ortiz B, Berberian AA, Noto C, Cordeiro Q, Belangero SI et al. Factor structure of the Positive and Negative Syndrome Scale (PANSS) in Brazil: convergent validation of the Brazilian version. Rev Bras Psiquiatr 2014; 36: 336\u2013339.","journal-title":"Rev Bras Psiquiatr"},{"key":"BFtp2016159_CR28","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.brainres.2012.06.032","volume":"1470","author":"W Zheng","year":"2012","unstructured":"Zheng W, Wang H, Zeng Z, Lin J, Little PJ, Srivastava LK et al. The possible role of the Akt signaling pathway in schizophrenia. Brain Res 2012; 1470: 145\u2013158.","journal-title":"Brain Res"},{"key":"BFtp2016159_CR29","doi-asserted-by":"publisher","first-page":"6541","DOI":"10.1002\/j.1460-2075.1996.tb01045.x","volume":"15","author":"DR Alessi","year":"1996","unstructured":"Alessi DR, Andjelkovic M, Caudwell B, Cron P, Morrice N, Cohen P et al. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J 1996; 15: 6541\u20136551.","journal-title":"EMBO J"},{"key":"BFtp2016159_CR30","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1146\/annurev.pharmtox.011008.145634","volume":"49","author":"JM Beaulieu","year":"2009","unstructured":"Beaulieu JM, Gainetdinov RR, Caron MG . Akt\/GSK3 signaling in the action of psychotropic drugs. Ann Rev Pharmacol Toxicol 2009; 49: 327\u2013347.","journal-title":"Ann Rev Pharmacol Toxicol"},{"key":"BFtp2016159_CR31","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.tibs.2004.03.006","volume":"29","author":"DP Brazil","year":"2004","unstructured":"Brazil DP, Yang ZZ, Hemmings BA . Advances in protein kinase B signalling: AKTion on multiple fronts. Trends Biochem Sci 2004; 29: 233\u2013242.","journal-title":"Trends Biochem Sci"},{"issue":"Suppl 3","key":"BFtp2016159_CR32","doi-asserted-by":"publisher","first-page":"iii70","DOI":"10.1136\/ard.2008.098459","volume":"67","author":"T Weichhart","year":"2008","unstructured":"Weichhart T, Saemann MD . The PI3K\/Akt\/mTOR pathway in innate immune cells: emerging therapeutic applications. Annals of the rheumatic diseases. Ann Rheum Dis 2008; 67 (Suppl 3): iii70\u2013iii74.","journal-title":"Ann Rheum Dis"},{"key":"BFtp2016159_CR33","doi-asserted-by":"publisher","first-page":"8745","DOI":"10.1073\/pnas.96.15.8745","volume":"96","author":"E Chalecka-Franaszek","year":"1999","unstructured":"Chalecka-Franaszek E, Chuang DM . Lithium activates the serine\/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons. Proc Natl Acad Sci USA 1999; 96: 8745\u20138750.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFtp2016159_CR34","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/S0028-3908(02)00215-0","volume":"43","author":"P De Sarno","year":"2002","unstructured":"De Sarno P, Li X, Jope RS . Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium. Neuropharmacology 2002; 43: 1158\u20131164.","journal-title":"Neuropharmacology"},{"key":"BFtp2016159_CR35","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/ng1296","volume":"36","author":"ES Emamian","year":"2004","unstructured":"Emamian ES, Hall D, Birnbaum MJ, Karayiorgou M, Gogos JA . Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat Genet 2004; 36: 131\u2013137.","journal-title":"Nat Genet"},{"key":"BFtp2016159_CR36","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.biopsych.2007.06.005","volume":"63","author":"DL Thiselton","year":"2008","unstructured":"Thiselton DL, Vladimirov VI, Kuo PH, McClay J, Wormley B, Fanous A et al. AKT1 is associated with schizophrenia across multiple symptom dimensions in the Irish study of high density schizophrenia families. Biol Psychiatry 2008; 63: 449\u2013457.","journal-title":"Biol Psychiatry"},{"key":"BFtp2016159_CR37","doi-asserted-by":"publisher","first-page":"e32618","DOI":"10.1371\/journal.pone.0032618","volume":"7","author":"NJ van Beveren","year":"2012","unstructured":"van Beveren NJ, Buitendijk GH, Swagemakers S, Krab LC, Roder C, de Haan L et al. Marked reduction of AKT1 expression and deregulation of AKT1-associated pathways in peripheral blood mononuclear cells of schizophrenia patients. PLoS ONE 2012; 7: e32618.","journal-title":"PLoS ONE"},{"key":"BFtp2016159_CR38","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.gde.2006.02.012","volume":"16","author":"RW Carthew","year":"2006","unstructured":"Carthew RW . Gene regulation by microRNAs. Curr Opin Genet Dev 2006; 16: 203\u2013208.","journal-title":"Curr Opin Genet Dev"},{"key":"BFtp2016159_CR39","doi-asserted-by":"publisher","first-page":"e678","DOI":"10.1038\/tp.2015.159","volume":"5","author":"AJ Forstner","year":"2015","unstructured":"Forstner AJ, Hofmann A, Maaser A, Sumer S, Khudayberdiev S, Muhleisen TW et al. Genome-wide analysis implicates microRNAs and their target genes in the development of bipolar disorder. Transl Psychiatry 2015; 5: e678.","journal-title":"Transl Psychiatry"},{"key":"BFtp2016159_CR40","doi-asserted-by":"publisher","first-page":"208","DOI":"10.2174\/1871527314666150116124253","volume":"14","author":"V Caputo","year":"2015","unstructured":"Caputo V, Ciolfi A, Macri S, Pizzuti A . The emerging role of MicroRNA in schizophrenia. CNS Neurol Disord Drug Targets 2015; 14: 208\u2013221.","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"BFtp2016159_CR41","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3109\/08820139.2013.863557","volume":"43","author":"AS Devasthanam","year":"2014","unstructured":"Devasthanam AS, Tomasi TB . Dicer in immune cell development and function. Immunol Invest 2014; 43: 182\u2013195.","journal-title":"Immunol Invest"},{"key":"BFtp2016159_CR42","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.biopsych.2010.09.030","volume":"69","author":"DM Santarelli","year":"2011","unstructured":"Santarelli DM, Beveridge NJ, Tooney PA, Cairns MJ . Upregulation of dicer and microRNA expression in the dorsolateral prefrontal cortex Brodmann area 46 in schizophrenia. Biol Psychiatry 2011; 69: 180\u2013187.","journal-title":"Biol Psychiatry"},{"key":"BFtp2016159_CR43","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1038\/mp.2009.84","volume":"15","author":"NJ Beveridge","year":"2010","unstructured":"Beveridge NJ, Gardiner E, Carroll AP, Tooney PA, Cairns MJ . Schizophrenia is associated with an increase in cortical microRNA biogenesis. Mol Psychiatry 2010; 15: 1176\u20131189.","journal-title":"Mol Psychiatry"},{"key":"BFtp2016159_CR44","doi-asserted-by":"publisher","first-page":"5001","DOI":"10.1093\/hmg\/ddt350","volume":"22","author":"AR Sanders","year":"2013","unstructured":"Sanders AR, Goring HH, Duan J, Drigalenko EI, Moy W, Freda J et al. Transcriptome study of differential expression in schizophrenia. Hum Mol Genet 2013; 22: 5001\u20135014.","journal-title":"Hum Mol Genet"},{"key":"BFtp2016159_CR45","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1007\/s12031-012-9887-1","volume":"49","author":"Y Zhou","year":"2013","unstructured":"Zhou Y, Wang J, Lu X, Song X, Ye Y, Zhou J et al. Evaluation of six SNPs of MicroRNA machinery genes and risk of schizophrenia. J Mol Neurosci 2013; 49: 594\u2013599.","journal-title":"J Mol Neurosci"},{"key":"BFtp2016159_CR46","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/ng.162","volume":"40","author":"B Xu","year":"2008","unstructured":"Xu B, Roos JL, Levy S, van Rensburg EJ, Gogos JA, Karayiorgou M . Strong association of de novo copy number mutations with sporadic schizophrenia. Nat Genet 2008; 40: 880\u2013885.","journal-title":"Nat Genet"},{"key":"BFtp2016159_CR47","doi-asserted-by":"publisher","first-page":"e82895","DOI":"10.1371\/journal.pone.0082895","volume":"8","author":"Z Zhang","year":"2013","unstructured":"Zhang Z, Convertini P, Shen M, Xu X, Lemoine F, de la Grange P et al. Valproic acid causes proteasomal degradation of DICER and influences miRNA expression. PLoS ONE 2013; 8: e82895.","journal-title":"PLoS ONE"},{"key":"BFtp2016159_CR48","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.pnpbp.2014.01.006","volume":"51","author":"H Yu","year":"2014","unstructured":"Yu H, Bi W, Liu C, Zhao Y, Zhang D, Yue W . A hypothesis-driven pathway analysis reveals myelin-related pathways that contribute to the risk of schizophrenia and bipolar disorder. Progress Neuropsychopharmacol Biol Psychiatry 2014; 51: 140\u2013145.","journal-title":"Progress Neuropsychopharmacol Biol Psychiatry"},{"key":"BFtp2016159_CR49","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.immuni.2006.04.007","volume":"24","author":"JM Feng","year":"2006","unstructured":"Feng JM, Hu YK, Xie LH, Colwell CS, Shao XM, Sun XP et al. Golli protein negatively regulates store depletion-induced calcium influx in T cells. Immunity 2006; 24: 717\u2013727.","journal-title":"Immunity"},{"key":"BFtp2016159_CR50","doi-asserted-by":"publisher","first-page":"7004","DOI":"10.1523\/JNEUROSCI.0288-05.2005","volume":"25","author":"EC Jacobs","year":"2005","unstructured":"Jacobs EC, Pribyl TM, Feng JM, Kampf K, Spreur V, Campagnoni C et al. Region-specific myelin pathology in mice lacking the golli products of the myelin basic protein gene. J Neurosci 2005; 25: 7004\u20137013.","journal-title":"J Neurosci"},{"key":"BFtp2016159_CR51","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.1523\/JNEUROSCI.4424-10.2011","volume":"31","author":"PM Paez","year":"2011","unstructured":"Paez PM, Fulton D, Spreuer V, Handley V, Campagnoni AT . Modulation of canonical transient receptor potential channel 1 in the proliferation of oligodendrocyte precursor cells by the golli products of the myelin basic protein gene. J Neurosc 2011; 31: 3625\u20133637.","journal-title":"J Neurosc"},{"key":"BFtp2016159_CR52","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jneuroim.2004.03.021","volume":"152","author":"JM Feng","year":"2004","unstructured":"Feng JM, Fernandes AO, Campagnoni CW, Hu YH, Campagnoni AT . The golli-myelin basic protein negatively regulates signal transduction in T lymphocytes. J Neuroimmunol 2004; 152: 57\u201366.","journal-title":"J Neuroimmunol"},{"key":"BFtp2016159_CR53","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.pneurobio.2015.09.002","volume":"134","author":"S Heyes","year":"2015","unstructured":"Heyes S, Pratt WS, Rees E, Dahimene S, Ferron L, Owen MJ et al. Genetic disruption of voltage-gated calcium channels in psychiatric and neurological disorders. Progress Neurobiol 2015; 134: 36\u201354.","journal-title":"Progress Neurobiol"},{"key":"BFtp2016159_CR54","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/S0165-0173(03)00203-0","volume":"43","author":"MS Lidow","year":"2003","unstructured":"Lidow MS . Calcium signaling dysfunction in schizophrenia: a unifying approach. Brain Res Brain Res Rev 2003; 43: 70\u201384.","journal-title":"Brain Res Brain Res Rev"},{"key":"BFtp2016159_CR55","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.jpsychires.2008.11.006","volume":"43","author":"D Martins-de-Souza","year":"2009","unstructured":"Martins-de-Souza D, Gattaz WF, Schmitt A, Maccarrone G, Hunyadi-Gulyas E, Eberlin MN et al. Proteomic analysis of dorsolateral prefrontal cortex indicates the involvement of cytoskeleton, oligodendrocyte, energy metabolism and new potential markers in schizophrenia. J Psychiatr Res 2009; 43: 978\u2013986.","journal-title":"J Psychiatr Res"},{"key":"BFtp2016159_CR56","doi-asserted-by":"publisher","first-page":"e38211","DOI":"10.1371\/journal.pone.0038211","volume":"7","author":"PR Matthews","year":"2012","unstructured":"Matthews PR, Eastwood SL, Harrison PJ . Reduced myelin basic protein and actin-related gene expression in visual cortex in schizophrenia. PLoS ONE 2012; 7: e38211.","journal-title":"PLoS ONE"},{"key":"BFtp2016159_CR57","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/S0140-6736(03)14289-4","volume":"362","author":"D Tkachev","year":"2003","unstructured":"Tkachev D, Mimmack ML, Ryan MM, Wayland M, Freeman T, Jones PB et al. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 2003; 362: 798\u2013805.","journal-title":"Lancet"},{"key":"BFtp2016159_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ijnp\/pyu015","volume":"18","author":"H Wesseling","year":"2015","unstructured":"Wesseling H, Gottschalk MG, Bahn S . Targeted multiplexed selected reaction monitoring analysis evaluates protein expression changes of molecular risk factors for major psychiatric disorders. Int J Neuropsychopharmacol 2015; 18: 1.","journal-title":"Int J Neuropsychopharmacol"},{"key":"BFtp2016159_CR59","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1017\/S1461145708009887","volume":"12","author":"K Baruch","year":"2009","unstructured":"Baruch K, Silberberg G, Aviv A, Shamir E, Bening-Abu-Shach U, Baruch Y et al. Association between golli-MBP and schizophrenia in the Jewish Ashkenazi population: are regulatory regions involved? Int J Neuropsychopharmacol 2009; 12: 885\u2013894.","journal-title":"Int J Neuropsychopharmacol"},{"key":"BFtp2016159_CR60","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1002\/jnr.21161","volume":"85","author":"S Narayan","year":"2007","unstructured":"Narayan S, Kass KE, Thomas EA . Chronic haloperidol treatment results in a decrease in the expression of myelin\/oligodendrocyte-related genes in the mouse brain. J Neurosci Res 2007; 85: 757\u2013765.","journal-title":"J Neurosci Res"},{"key":"BFtp2016159_CR61","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1196\/annals.1316.011","volume":"1025","author":"T Sugai","year":"2004","unstructured":"Sugai T, Kawamura M, Iritani S, Araki K, Makifuchi T, Imai C et al. Prefrontal abnormality of schizophrenia revealed by DNA microarray: impact on glial and neurotrophic gene expression. Ann N Y Acad Sci 2004; 1025: 84\u201391.","journal-title":"Ann N Y Acad Sci"},{"key":"BFtp2016159_CR62","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1002\/cm.20532","volume":"68","author":"M Chansard","year":"2011","unstructured":"Chansard M, Hong JH, Park YU, Park SK, Nguyen MD. Ndel1 Nudel . (Noodle): flexible in the cell? Cytoskeleton 2011; 68: 540\u2013554.","journal-title":"Cytoskeleton"},{"key":"BFtp2016159_CR63","doi-asserted-by":"publisher","first-page":"7812","DOI":"10.1128\/MCB.25.17.7812-7827.2005","volume":"25","author":"S Sasaki","year":"2005","unstructured":"Sasaki S, Mori D, Toyo-oka K, Chen A, Garrett-Beal L, Muramatsu M et al. Complete loss of Ndel1 results in neuronal migration defects and early embryonic lethality. Mol Cell Biol 2005; 25: 7812\u20137827.","journal-title":"Mol Cell Biol"},{"key":"BFtp2016159_CR64","doi-asserted-by":"publisher","first-page":"e14583","DOI":"10.1371\/journal.pone.0014583","volume":"6","author":"M Chansard","year":"2011","unstructured":"Chansard M, Wang J, Tran HC, Neumayer G, Shim SY, Park YU et al. The cytoskeletal protein Ndel1 regulates dynamin 2 GTPase activity. PLoS ONE 2011; 6: e14583.","journal-title":"PLoS ONE"},{"key":"BFtp2016159_CR65","doi-asserted-by":"publisher","first-page":"3828","DOI":"10.1073\/pnas.0500330102","volume":"102","author":"MA Hayashi","year":"2005","unstructured":"Hayashi MA, Portaro FC, Bastos MF, Guerreiro JR, Oliveira V, Gorrao SS et al. Inhibition of NUDEL (nuclear distribution element-like)-oligopeptidase activity by disrupted-in-schizophrenia 1. Proc Natl Acad Sci USA. 2005; 102: 3828\u20133833.","journal-title":"Proc Natl Acad Sci USA."},{"key":"BFtp2016159_CR66","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1006\/bbrc.2000.2243","volume":"269","author":"MA Hayashi","year":"2000","unstructured":"Hayashi MA, Portaro FC, Tambourgi DV, Sucupira M, Yamane T, Fernandes BL et al. Molecular and immunochemical evidences demonstrate that endooligopeptidase A is the predominant cytosolic oligopeptidase of rabbit brain. Biochem Biophys Res Commun 2000; 269: 7\u201313.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFtp2016159_CR67","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/S0896-6273(00)00142-2","volume":"28","author":"O Reiner","year":"2000","unstructured":"Reiner O . LIS1. let's interact sometimes... (part 1). Neuron 2000; 28: 633\u2013636.","journal-title":"Neuron"},{"key":"BFtp2016159_CR68","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/sj.mp.4000975","volume":"7","author":"O Reiner","year":"2002","unstructured":"Reiner O, Cahana A, Escamez T, Martinez S . LIS1-no more no less. Mol Psychiatry 2002; 7: 12\u201316.","journal-title":"Mol Psychiatry"},{"key":"BFtp2016159_CR69","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.biopsych.2009.01.014","volume":"65","author":"L Tomppo","year":"2009","unstructured":"Tomppo L, Hennah W, Lahermo P, Loukola A, Tuulio-Henriksson A, Suvisaari J et al. Association between genes of Disrupted in schizophrenia 1 (DISC1) interactors and schizophrenia supports the role of the DISC1 pathway in the etiology of major mental illnesses. Biol Psychiatry 2009; 65: 1055\u20131062.","journal-title":"Biol Psychiatry"},{"key":"BFtp2016159_CR70","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1093\/hmg\/ddm207","volume":"16","author":"OM Palo","year":"2007","unstructured":"Palo OM, Antila M, Silander K, Hennah W, Kilpinen H, Soronen P et al. Association of distinct allelic haplotypes of DISC1 with psychotic and bipolar spectrum disorders and with underlying cognitive impairments. Hum Mol Genet 2007; 16: 2517\u20132528.","journal-title":"Hum Mol Genet"},{"key":"BFtp2016159_CR71","doi-asserted-by":"crossref","first-page":"353","DOI":"10.31887\/DCNS.2006.8.3\/blipska","volume":"8","author":"BK Lipska","year":"2006","unstructured":"Lipska BK, Mitkus SN, Mathew SV, Fatula R, Hyde TM, Weinberger DR et al. Functional genomics in postmortem human brain: abnormalities in a DISC1 molecular pathway in schizophrenia. Dialogues Clin Neurosci 2006; 8: 353\u2013357.","journal-title":"Dialogues Clin Neurosci"},{"key":"BFtp2016159_CR72","doi-asserted-by":"publisher","first-page":"e99892","DOI":"10.1371\/journal.pone.0099892","volume":"9","author":"A Rampino","year":"2014","unstructured":"Rampino A, Walker RM, Torrance HS, Anderson SM, Fazio L, Di Giorgio A et al. Expression of DISC1-interactome members correlates with cognitive phenotypes related to schizophrenia. PLoS ONE 2014; 9: e99892.","journal-title":"PLoS ONE"},{"key":"BFtp2016159_CR73","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1073\/pnas.252784499","volume":"100","author":"AR Whitney","year":"2003","unstructured":"Whitney AR, Diehn M, Popper SJ, Alizadeh AA, Boldrick JC, Relman DA et al. Individuality and variation in gene expression patterns in human blood. Proc Natl Acad Sci USA. 2003; 100: 1896\u20131901.","journal-title":"Proc Natl Acad Sci USA."}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/tp2016159.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tp2016159","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tp2016159.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T03:51:48Z","timestamp":1672804308000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/tp2016159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,4]]},"references-count":73,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2016,10]]}},"alternative-id":["BFtp2016159"],"URL":"https:\/\/doi.org\/10.1038\/tp.2016.159","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,4]]},"assertion":[{"value":"2 May 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"CN has received a scholarship from Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior (CAPES) and has served as a consultant or advisory board member for Janssen. AG was on the speakers\u2019 bureau and\/or has acted as a consultant for Janssen-Cilag in the last 12 months and has also received research support from Brazilian government institutions (CNPq). EB has been supported by CNPq, CAPES and FAPESP. RAB has received research funding from FAPESP, CNPq, CAPES, Funda\u00e7\u00e3o Safra, Funda\u00e7\u00e3o ABADS, Janssen, Eli Lilly, Lundbeck, Novartis and Roche, has served as a speaker for Astra Zeneca, Bristol, Janssen, Lundbeck and Revista Brasileira de Psiquiatria and is a shareholder of Radiopharmacus Ltda and Biomolecular Technology. The remaining authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}